Dear ABIT users:
We are glad to announce that ABIT now collaborates with Bitcurate team to launch the official BTCR airdrop on ABIT.com.
Airdrop Details:
- From June 22 till June 28, 2020 (ending at Singapore Time 18:00, GMT+8), the first 1,000 eligible applicants will receive 2 BTCR airdrop per person after completing corresponding tasks.
- The airdrop will be distributed in 3 business days after the end of the airdrop application collection. All eligible participants will be able to check it in their ABIT account balance then.
- Each account only has one opportunity to receive the airdrop.
- ABIT.com reserves all the rights of the final explanation of this activity.
Participation Procedures:
- Sign up accounts on ABIT.com or its official APP
- Join the official Telegram group of ABIT: https://t.me/abitofficial
- Join the Bitcurate LIVEFEED News Updates on Telegram: https://t.me/bitcuratelivefeed
- Join the Bitcurate LIVEFEED Price Alert on Telegram: https://t.me/bitcuratealerts
- Join the Bitcurate Community on Telegram: https://t.me/bitcuratecommunity
- Fill in the BTCR airdrop application form: https://docs.google.com/forms/d/1I-nxpcDLN4j4PgqGb9l_jtDS5kY6zP1APg3mj7H7oY4
Project Introduction
Bitcurate is predictive data analytics for cryptocurrency that help better decision-making through data-driven insights powered by AI and sentiment analysis. Bitcurate aims to bring transparency to the cryptocurrency industry. It helps investors, traders, and the fund managers make better decisions and is building models, algorithms and data science tools that brings data-driven decision making to their investments. Bitcurate is dedicated to enable more market participants to access to the future of money and decentralize finance.
Official Website:https://www.bitcurate.com/
Risk Warning: Digital assets are innovative investment products with great prices fluctuation. Please make a rational judgment on your investment ability and make investment decisions cautiously. We wish you a pleasant deal.
ABIT Offcial
2020.06.21
Comments
0 comments
Article is closed for comments.